New York City Risperdal Lawsuit Attorney

There are currently more than 5,500 Risperdal lawsuits awaiting trial — and all over the same issue regarding the defective drug. The parents of thousands of children who took the antipsychotic medication for bipolar disorder, autism or schizophrenia say that the drug caused their young boys to develop permanent breast tissue that could only be removed via surgery.

There are currently 10 Risperdal trials set to take place during the remainder of 2017 and into 2018. Recent past settlements include:

  • A Tennessee family was awarded $70 million in July 2016 after their 5-year-old boy developed breast tissue from the drug.
  • In December 2015, the family of a young boy received $500,000 in damages.
  • A jury awarded $1.75 million to a man November 2015 in Philadelphia who developed breasts after taking the medication for schizophrenia.
  • In February 2015, a family harmed by Risperdal was awarded $2.5 million in compensation.

There is still time to take action against the pharmaceutical company Johnson & Johnson and receive the compensation that you and your family need and deserve. Compensation may include:

  • Funds for past medical bills
  • Funds for future medical bills, including the removal of breast tissue
  • Compensation for pain and suffering
  • Punitive damages

If your son or loved one has suffered from the permanent side effects of Risperdal, speak with a New York City Risperdal lawsuit lawyer today about your case. Meirowitz & Wasserberg, LLP, wants to hear your story and help.

Facts About Risperdal

Generic name: Risperidone

Drug type: Antipsychotic 

Treatments approved for: Schizophrenia, bipolar disorder, dementia, autism.

Possible side effects: Permanent movement problems, vision problems, sleep problems, weight gain, high blood sugar, and increased risk of suicide. In elderly dementia patients, risk of early death. In prepubescent boys, the development of permanent breast tissue (gynecomastia).

Development: Studied and developed in the 1980s

FDA Approval: 1993

Manufacturer: Johnson & Johnson

Administration: Oral medication or injection

Risperdal: A History Of Violations And Lawsuits

Risperdal was originally developed in the early 1990s and approved by the FDA solely as an antipsychotic to treat schizophrenia in adults. However, the drug’s manufacturer, Johnson & Johnson, soon pushed to market the medication to two other groups in order to increase profits: children and senior citizens. They also wanted the drug approved for treatments outside of schizophrenia.

Even though the FDA never approved the drug’s use in seniors and children, the pharmaceutical company began to market the drug to those groups, and for disorders like autism and bipolar disorder. They ignored mounting evidence that the drug caused higher rates of death among the elderly or that a shocking 5% of boys who used the drug developed breasts and suffered from weight gain due to hormone imbalances caused by the drug.

Only in 2006 did the FDA approve the drug for use in children with autism, but by 2012, Johnson & Johnson was made to pay a $2.2 billion fine for their violations of marketing rules, one of the biggest drug company fines in history. Finally, in November 2015, over 1,000 defective drug lawsuits involving Risperdal and gynecomastia were consolidated into a mass tort.

Risperdal Defection Drug Lawyers | Meirowitz & Wasserberg

Seeking compensation for the harm done to you or your loved one can not only secure compensation for your losses, but also prevent Johnson & Johnson from causing similar harm to others. During a confidential, no-obligation consultation, we can listen to your story, look at the evidence of your case, and help you take the next step.